SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...
Hypertension is one of the most common chronic conditions in the U.S., affecting nearly half of the country’s adults, according to the Centers for Disease Control and Prevention. Unfortunately, ...
For patients with hypertension, initiating treatment with an ARB is associated with the best long-term class persistence.
The FDA has issued a complete response letter for an oral selective glucocorticoid receptor antagonist under investigation ...
Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...
Diagnostic delays in hypertension lead to lower treatment rates and increased cardiovascular risk, with prescription rates decreasing as delays lengthen. Delayed diagnoses correlate with a higher risk ...
The American Heart Association and the American the College of Cardiology in 2025 issued guidelines to help reduce ...
New research links blood pressure treatment to anxiety in women and reduced vitality in men, calling for personalized mental health support. Study: Blood pressure status, quality of life, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback